Form 4: DocuSign Director Anna Marrs Converts RSUs to Common Stock
Insider Transaction Report
DocuSign Director Anna Marrs reported the conversion of 725 restricted stock units into common stock, part of a pre-arranged vesting schedule.
Summary
- Anna Marrs, a Director at DocuSign, Inc. (DOCU), reported a transaction involving the company's securities.
- On September 4, 2025, Marrs acquired 725 shares of DocuSign Common Stock at a price of $0.
- This acquisition resulted from the conversion of 725 Restricted Stock Units (RSUs).
- Following this transaction, Marrs beneficially owns 11,527 shares of Common Stock and 2,175 Restricted Stock Units.
- The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged schedule for the purchase or sale of equity securities.
- The RSUs vest in twelve equal quarterly installments over three years, commencing June 4, 2023.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The transaction is a routine vesting of equity compensation, which is an expected part of a director's compensation package and aligns interests with shareholders. It's not a sale, which would typically be viewed more negatively.
Positives
- The transaction represents a routine vesting and conversion of Restricted Stock Units (RSUs) into common stock, which is an expected part of a director's compensation.
- The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled and transparent transaction, reducing concerns about opportunistic insider trading.
Negatives
- No direct negatives are apparent from this routine RSU vesting and conversion.
Future Outlook
The filing indicates that the remaining Restricted Stock Units will continue to vest in twelve equal quarterly installments over three years from the June 4, 2023 commencement date, subject to the reporting person's continued service.
Industry Context
This is a routine insider transaction related to equity compensation, common across publicly traded companies, particularly in the technology sector, to align executive and director interests with shareholders. It does not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: The conversion of RSUs into common stock increases the number of outstanding shares, though the impact from 725 shares is negligible. It also aligns the director's interests with shareholders through direct stock ownership.
- Employees: No direct impact on employees is indicated by this specific filing.
- Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated.
Next Steps
- Remaining Restricted Stock Units will continue to vest in twelve equal quarterly installments over three years from June 4, 2023, contingent on continued service.
Key Dates
| Date | Description |
|---|---|
| 06/04/2023 | Vesting commencement date for the Restricted Stock Units. |
| 09/04/2025 | Date of transaction where 725 Restricted Stock Units were converted into Common Stock. |
Recommendation
holdThis Form 4 filing reports a routine, pre-scheduled vesting and conversion of Restricted Stock Units by a director. It does not provide new fundamental information about DocuSign's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It simply reflects an expected part of executive compensation and insider ownership alignment. Therefore, a 'hold' recommendation is appropriate as there's no new catalyst for a 'buy' or 'sell' decision based solely on this filing.
Keywords
DocuSign, DOCU, Anna Marrs, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director, Equity Compensation, Stock Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.